{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:27:38Z","timestamp":1790684858929,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2018.00364","type":"journal-article","created":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T23:31:13Z","timestamp":1547422273000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":150,"title":["IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels"],"prefix":"10.3389","volume":"5","author":[{"given":"Marie","family":"Robert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in Chronic Inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/ard.2010.143768","article-title":"Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/annrheumdis-2014-207110","article-title":"A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis","volume":"74","author":"Ndongo-Thiam","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","article-title":"Therapeutic Targeting of IL-17 and IL-23 cytokines in immune-mediated diseases","volume":"67","author":"Fragoulis","year":"2016","journal-title":"Annu Rev Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","article-title":"Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3","volume":"19","author":"Pavelka","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/annrheumdis-2016-210023","article-title":"Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study","volume":"76","author":"Sieper","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/annrheumdis-2016-209149","article-title":"Negative association between autoantibodies against IL-17, IL-17\/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis","volume":"75","author":"Ndongo-Thiam","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.2174\/1381612821666150310145758","article-title":"Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology","volume":"21","author":"Astorri","year":"2015","journal-title":"Curr Pharm Des."},{"key":"B12","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1074\/jbc.M008289200","article-title":"IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"J Exp Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jaci.2007.07.051","article-title":"Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma","volume":"120","author":"Ballantyne","year":"2007","journal-title":"J Aller Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J Exp Med."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4049\/jimmunol.162.3.1246","article-title":"IL-17 is produced by some proinflammatory Th1\/Th0 cells but not by Th2 cells","volume":"162","author":"Aarvak","year":"1999","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity."},{"key":"B26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.4049\/jimmunol.181.6.4299","article-title":"Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities","volume":"181","author":"Rickel","year":"2008","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 Signaling: the Yin and the Yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","article-title":"Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes","volume":"182","author":"Zrioual","year":"2009","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"ra72","DOI":"10.1126\/scisignal.2001843","article-title":"A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation","volume":"4","author":"Liu","year":"2011","journal-title":"Sci Signal."},{"key":"B32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","article-title":"Rheumatoid arthritis: regulation of synovial inflammation","volume":"36","author":"Sweeney","year":"2004","journal-title":"Int J Biochem Cell Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini","year":"2013","journal-title":"Nat Rev Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/rheumatology\/40.5.522","article-title":"High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients","volume":"40","author":"Honorati","year":"2001","journal-title":"Rheumatology (Oxford)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/art.34391","article-title":"Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis","volume":"64","author":"Eljaafari","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13075-016-1046-6","article-title":"Interaction among activated lymphocytes and mesenchymal cells through podoplanin is critical for a high IL-17 secretion","volume":"18","author":"Noack","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/cei.12830","article-title":"Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells","volume":"186","author":"Noack","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0002-9440(10)63131-8","article-title":"Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression","volume":"164","author":"Page","year":"2004","journal-title":"Am J Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.4049\/jimmunol.167.10.6015","article-title":"Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines","volume":"167","author":"Chabaud","year":"2001","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","article-title":"Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis","volume":"12","author":"Chabaud","year":"2000","journal-title":"Cytokine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/ar294","article-title":"IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis","volume":"3","author":"Chabaud","year":"2001","journal-title":"Arthritis Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2015.00151","article-title":"Differential Effects of IL-17A and TNF-alpha on osteoblastic differentiation of isolated synoviocytes and on bone explants from arthritis patients","volume":"6","author":"Osta","year":"2015","journal-title":"Front Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ard.2010.132233","article-title":"IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar1038","article-title":"IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase\/Akt-dependent pathways","volume":"6","author":"Hwang","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/eji.201344184","article-title":"Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis","volume":"44","author":"Benedetti","year":"2014","journal-title":"Eur J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4049\/jimmunol.180.1.655","article-title":"IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood","volume":"180","author":"Zrioual","year":"2008","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molimm.2012.08.018","article-title":"Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-kappaB\/HIF-1alpha pathway","volume":"53","author":"Li","year":"2013","journal-title":"Mol Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2011-200867","article-title":"IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies","volume":"11","author":"Moran","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S8756-3282(00)00457-9","article-title":"Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)\/RANK ligand signaling?","volume":"28","author":"Van Bezooijen","year":"2001","journal-title":"Bone."},{"key":"B56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cyto.2016.09.019","article-title":"T-cell clones from Th1, Th17 or Th1\/17 lineages and their signature cytokines have different capacity to activate endothelial cells or synoviocytes","volume":"88","author":"Lavocat","year":"2016","journal-title":"Cytokine."},{"key":"B57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bone.2016.04.008","article-title":"Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-alpha and IL-17A induced osteoblastic differentiation","volume":"87","author":"Lavocat","year":"2016","journal-title":"Bone."},{"key":"B58","doi-asserted-by":"publisher","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Uluckan","year":"2016","journal-title":"Sci Transl Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.semarthrit.2008.10.008","article-title":"Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis","volume":"39","author":"Daoussis","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"B60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","article-title":"Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts","volume":"14","author":"Honorati","year":"2006","journal-title":"Osteoarthritis Cartilage."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1002\/art.24999","article-title":"A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"60","author":"Zhang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B62","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar4179","article-title":"IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation","volume":"15","author":"Lee","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fimmu.2016.00254","article-title":"IL-17A and TNF-alpha Increase the Expression of the Antiapoptotic Adhesion Molecule Amigo-2 in Arthritis Synoviocytes","volume":"7","author":"Benedetti","year":"2016","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e13416","DOI":"10.1371\/journal.pone.0013416","article-title":"Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression","volume":"5","author":"Toh","year":"2010","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2565","DOI":"10.1038\/cddis.2016.490","article-title":"IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy","volume":"8","author":"Kim","year":"2017","journal-title":"Cell Death Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"Hartupee","year":"2007","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.4049\/jimmunol.182.3.1660","article-title":"IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6","volume":"182","author":"Hartupee","year":"2009","journal-title":"J Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/ar2406","article-title":"Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha","volume":"10","author":"Parsonage","year":"2008","journal-title":"Arthritis Res Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"R186","DOI":"10.1186\/ar762","article-title":"Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6","volume":"5","author":"Kehlen","year":"2003","journal-title":"Arthritis Res Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.intimp.2012.12.010","article-title":"Synergistic effects of interleukin-1beta and interleukin-17A antibodies on collagen-induced arthritis mouse model","volume":"15","author":"Zhang","year":"2013","journal-title":"Int Immunopharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2016.09.001","article-title":"The bispecific antibody aimed at the vicious circle of IL-1beta and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-kappaB signaling pathway","volume":"179","author":"Wu","year":"2016","journal-title":"Immunol Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1172\/JCI113971","article-title":"Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions","volume":"83","author":"Xu","year":"1989","journal-title":"J Clin Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13075-015-0683-5","article-title":"Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-kappaB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis","volume":"17","author":"van Nieuwenhuijze","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of Interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes."},{"key":"B78","doi-asserted-by":"publisher","first-page":"36002","DOI":"10.1038\/srep36002","article-title":"IL-25 attenuates rheumatoid arthritis through suppression of Th17 immune responses in an IL-13-dependent manner","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fimmu.2017.00647","article-title":"Interleukin-25 Produced by Synoviocytes Has Anti-inflammatory Effects by Acting As a Receptor Antagonist for Interleukin-17A Function","volume":"8","author":"Lavocat","year":"2017","journal-title":"Front Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1053\/j.gastro.2009.02.049","article-title":"Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut","volume":"136","author":"Caruso","year":"2009","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2008-08-172767","article-title":"Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3","volume":"113","author":"Caruso","year":"2009","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-3083.1997.d01-139.x","article-title":"High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study","volume":"46","author":"Jouvenne","year":"1997","journal-title":"Scand J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard.61.7.577","article-title":"Anti-interleukin 1alpha autoantibodies","volume":"61","author":"Miossec","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/344633a0","article-title":"Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein","volume":"344","author":"Carter","year":"1990","journal-title":"Nature."},{"key":"B85","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9","article-title":"Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction","volume":"41","author":"Jouvenne","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B86","doi-asserted-by":"publisher","first-page":"735342","DOI":"10.1155\/2012\/735342","article-title":"Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients","volume":"2012","author":"Lechner","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.61.8.730","article-title":"Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation","volume":"61","author":"Chevrel","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T","article-title":"The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model","volume":"44","author":"Chabaud","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B89","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/ar1465","article-title":"Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response","volume":"7","author":"Marotte","year":"2005","journal-title":"Arthritis Res Ther."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/art.10388","article-title":"High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment","volume":"46","author":"Ziolkowska","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B91","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jbspin.2015.03.002","article-title":"Intra-articular etanercept treatment in inflammatory arthritis: a randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment","volume":"82","author":"Aalbers","year":"2015","journal-title":"Joint Bone Spine."},{"key":"B92","first-page":"73","article-title":"IL-17 patterns in synovium, serum and synovial fluid from treatment-naive, early rheumatoid arthritis patients","volume":"53","author":"Rosu","year":"2012","journal-title":"Rom J Morphol Embryol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New learnings on the pathophysiology of RA from synovial biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrrheum.2015.17","article-title":"Trojan horses and guided missiles: targeted therapies in the war on arthritis","volume":"11","author":"Ferrari","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13075-016-0919-z","article-title":"Higher expression of TNFalpha-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy","volume":"18","author":"De Groof","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"E530","DOI":"10.3390\/ijms19020530","article-title":"Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints","volume":"19","author":"Boutet","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.autrev.2006.08.013","article-title":"The synovial membrane as a prognostic tool in rheumatoid arthritis","volume":"6","author":"Humby","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fmed.2017.00041","article-title":"Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?","volume":"4","author":"Humby","year":"2017","journal-title":"Front Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2010.09.004","article-title":"Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF","volume":"362","author":"DeForge","year":"2010","journal-title":"J Immunol Methods."},{"key":"B100","first-page":"2285","article-title":"Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/jlpm.2017.02.01","article-title":"Environmental exposures and biomarkers predictive of rheumatoid arthritis and the pathway to precision medicine","volume":"2","author":"Bernatsky","year":"2017","journal-title":"J Lab Precis Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00296-016-3480-9","article-title":"Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials","volume":"36","author":"Kunwar","year":"2016","journal-title":"Rheumatol Int."},{"key":"B103","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"van Baarsen","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/19420862.2015.1093266","article-title":"Discovery and characterization of COVA322, a clinical-stage bispecific TNF\/IL-17A inhibitor for the treatment of inflammatory diseases","volume":"8","author":"Silacci","year":"2016","journal-title":"MAbs."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/art.40580","article-title":"ABT-122, a bispecific dual variable domain immunoglobulin targeting tumor necrosis factor and Interleukin-17A, in patients with rheumatoid arthritis with an inadequate Response to methotrexate: a randomized, double-blind study","volume":"70","author":"Genovese","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key312","article-title":"Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis","author":"Khatri","year":"2018","journal-title":"Rheumatology"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T18:02:43Z","timestamp":1694541763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2018.00364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":106,"alternative-id":["10.3389\/fmed.2018.00364"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2018.00364","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"article-number":"364"}}